NVO
Novo Nordisk A/S
37.30$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 16.4% | 15.0% | 15.4% | 15.8% | 15.8% | 16.5% | 16.5% | 16.8% | 16.1% | 15.4% | 15.3% | 19.0% | |
| 83.6% | 85.0% | 84.6% | 84.2% | 84.2% | 83.5% | 83.5% | 83.2% | 83.9% | 84.6% | 84.7% | 81.0% | |
| 15.5% | 12.6% | 13.0% | 12.5% | 13.2% | 11.7% | 12.2% | 12.6% | 13.6% | 14.0% | 16.6% | 16.8% | |
| 4.0% | 3.6% | 3.5% | 3.4% | 3.5% | 3.3% | 3.1% | 2.9% | 2.5% | 2.1% | 1.8% | 1.9% | |
| 44.8% | 39.2% | 41.3% | 40.4% | 42.0% | 40.5% | 40.9% | 41.5% | 41.6% | 40.4% | 40.5% | 39.7% | |
| 38.8% | 45.8% | 43.3% | 43.8% | 42.2% | 43.0% | 42.6% | 41.7% | 42.3% | 44.2% | 44.2% | 41.3% | |
| 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.6% | 1.4% | |
| 38.4% | 40.3% | 42.8% | 43.6% | 42.6% | 39.8% | 41.9% | 42.0% | 39.0% | 45.1% | 43.8% | 42.2% | |
| 8.6% | 8.0% | 8.8% | 9.4% | 8.0% | 7.9% | 8.7% | 8.0% | 7.7% | 9.0% | 9.0% | 9.1% | |
| 29.8% | 32.3% | 33.9% | 34.1% | 34.5% | 31.9% | 33.2% | 33.9% | 31.4% | 36.0% | 34.8% | 33.1% | |
| 42.3% | 43.1% | 45.7% | 46.5% | 46.2% | 44.6% | 46.7% | 46.4% | 43.4% | 49.4% | 50.9% | 50.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.